抑制BMP信号通路诱导间变性脑膜瘤衰老与钙化
该研究探讨BMP信号抑制剂K02288及上游调控因子GREM2对脑膜瘤生长和衰老的影响,发现抑制BMPR1A或过表达GREM2可使恶性脑膜瘤色氨酸代谢从犬尿氨酸/喹啉酸转向5-羟色胺,降低NAD+/NADH和氧化磷酸化基因表达,减少ATP,导致细胞衰老、增殖下降并形成砂粒体。公共数据库RNA-seq再分析显示GREM2高表达降低氧化磷酸化基因表达,与实验一致。作者认为GREM2-BMPR1A-色氨酸代谢通路是潜在新治疗靶点。
要点
- 抑制BMPR1A或过表达GREM2使恶性脑膜瘤色氨酸代谢转向5-羟色胺,降低NAD+/NADH和ATP。
- 上述干预导致恶性脑膜瘤细胞衰老、增殖下降并最终形成砂粒体。
- 公共数据库再分析显示GREM2高表达降低氧化磷酸化基因表达,与实验一致。
核心结论
- 脑膜瘤中的GREM2-BMPR1A-色氨酸代谢通路是潜在的新治疗靶点。
研究设计与样本
- 研究检测BMP信号抑制剂K02288和上游调控因子GREM2对脑膜瘤生长和衰老的影响,包括增殖实验、强制表达GREM2的综合分析、87例临床样本中GREM2 mRNA与增殖标志物的相关性、公共数据库GREIN的42例RNA-seq数据高/低表达组富集分析,以及BMP信号抑制相关代谢物和衰老标志物变化。
主要发现
- 抑制BMPR1A和强制表达GREM2使恶性脑膜瘤色氨酸代谢从犬尿氨酸/喹啉酸生成转向5-羟色胺生成,降低NAD+/NADH生成,减少氧化磷酸化相关基因簇表达,并导致ATP减少。
- 恶性脑膜瘤发生细胞衰老、增殖下降并最终形成砂粒体。
- 来自GREIN的临床样本RNA-seq数据再分析显示,GREM2表达增加降低氧化磷酸化相关基因表达,与实验 results 相似。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Meningiomas are the most common type of brain tumors and are generally benign, but malignant atypical meningiomas and anaplastic meningiomas frequently recur with poor prognosis. The metabolism of meningiomas is little known, so few effective treatment options other than surgery and radiation are available, and the targets for treatment of recurrence are not well defined. The Aim of this paper is to find the therapeutic target. METHODS: The effects of bone morphogenetic protein (BMP) signal inhibitor (K02288) and upstream regulator Gremlin2 (GREM2) on meningioma's growth and senescence were examined. In brief, we examined as follows: 1) Proliferation assay by inhibiting BMP signaling. 2) Comprehensive analysis of forced expression GREM2.3) Correlation between GREM2 mRNA expression and proliferation marker in 87 of our clinical samples. 4) Enrichment analysis between GREM2 high/low expressed groups using RNA-seq data (42 cases) from the public database GREIN. 5) Changes in metabolites and senescence markers associated with BMP signal suppression. RESULTS: Inhibitors of BMP receptor (BMPR1A) and forced expression of GREM2 shifted tryptophan metabolism from kynurenine/quinolinic acid production to serotonin production in malignant meningiomas, reduced NAD + /NADH production, decreased gene cluster expression involved in oxidative phosphorylation, and caused decrease in ATP. Finally, malignant meningiomas underwent cellular senescence, decreased proliferation, and eventually formed psammoma bodies. Reanalyzed RNA-seq data of clinical samples obtained from GREIN showed that increased expression of GREM2 decreased the expression of genes involved in oxidative phosphorylation, similar to our experimental results. CONCLUSIONS: The GREM2-BMPR1A-tryptophan metabolic pathway in meningiomas is a potential new therapeutic target.
引用
- Yokogami K, Watanabe T, Yamashita S, et al. Inhibition of BMP signaling pathway induced senescence and calcification in anaplastic meningioma. J Neurooncol. 2024. PMID: 38446374. doi:10.1007/s11060-024-04625-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。